Future studies need to focus on investigating the effects of ADM-activated PP2A and aldosterone-stimulated calcineurin in water imbalance-related diseases such as hyponatremia associated with vasopressin escape, thus providing a new strategy for treating the disease. Here, PTPA is linked to Hyponatremia.